title: The role of big endothelin-1 in colorectal cancer.
abstract: BACKGROUND
  Changes in liver blood flow caused by an unknown splanchnic vasoconstrictor have been noted in colorectal cancer patients with liver metastases. This prospective study was performed to assess whether plasma levels of big endothelin-1 (big ET-1) were raised in patients with colorectal cancer.
  
  
  METHODS
  Plasma samples from peripheral vein of patients who underwent surgery for primary colorectal cancer (n=60) and those with known colorectal liver metastases (n=45) for a period of 15 months were taken prior to treatment and compared to age- and sex-matched controls (n=20). Plasma samples were analysed by using a single-step sandwich enzyme immunoassay. Immunohistochemistry and in situ hybridisation were also performed on tumour sections to investigate the expression of ET-1 by cancer cells.
  
  
  RESULTS
  The median (range) plasma concentration of big ET-1 in controls was 2.1 pg/mL (1.2-13.4 pg/mL). The median (range) plasma concentration of big ET-1 in colorectal cancer patients with no overt hepatic metastases was 3.8 pg/mL (1.2-15.8 pg/mL), p=0.002, and the median (range) plasma concentration of big ET-1 in colorectal cancer patients with hepatic metastases was 5.2 pg/mL (1.7-30 pg/mL), p=0.0001; both were significantly elevated compared to the control group. A significant difference in immunostaining for big ET-1 was noted between paired normal colonic mucosa (median score-1) and tumour sections (median score-3), p=0.01.
  
  
  CONCLUSIONS
  This study has demonstrated elevated concentrations of big ET-1 in colorectal cancer patients, especially in those with hepatic metastases. Upregulation of ET activity in colorectal cancer could be inferred by the increased immunostaining of big ET-1 in cancer cells. Therefore, plasma big ET-1 levels should be evaluated as a potential tumour marker for the identification of hepatic metastases at an earlier stage.
authors.affiliation: University Department of Surgery, Leicester Royal Infirmary, Leicester, United Kingdom.
authors.forename: C
authors.initials: C
authors.lastname: Arun
authors.forename: B
authors.initials: B
authors.lastname: Swift
authors.forename: K E
authors.initials: KE
authors.lastname: Porter
authors.forename: K P
authors.initials: KP
authors.lastname: West
authors.forename: N J M
authors.initials: NJ
authors.lastname: London
authors.forename: D M
authors.initials: DM
authors.lastname: Hemingway
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D015179:Colorectal Neoplasms / Q000097:blood*; D019332:Endothelin-1; D016232:Endothelins / Q000032:analysis / Q000097:blood* / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D011498:Protein Precursors / Q000032:analysis / Q000097:blood* / Q000502:physiology; D012189:Retrospective Studies
chemical_list: D014408:Biomarkers, Tumor; D019332:Endothelin-1; D016232:Endothelins; D011498:Protein Precursors